Brian C. Broderick’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-5,849
| Closed | -$219K | – | 93 |
|
|
2016
Q4 | $219K | Sell |
5,849
-20
| -0.3% | -$749 | 0.09% | 90 |
|
|
2016
Q3 | $398K | Sell |
5,869
-113
| -2% | -$7.66K | 0.17% | 78 |
|
|
2016
Q2 | $331K | Buy |
5,982
+1,010
| +20% | +$55.9K | 0.14% | 84 |
|
|
2016
Q1 | $313K | Buy |
4,972
+47
| +1% | +$2.96K | 0.14% | 87 |
|
|
2015
Q4 | $464K | Buy |
4,925
+40
| +0.8% | +$3.77K | 0.21% | 75 |
|
|
2015
Q3 | $393K | Sell |
4,885
-102
| -2% | -$8.21K | 0.18% | 76 |
|
|
2015
Q2 | $597K | Sell |
4,987
-40
| -0.8% | -$4.79K | 0.25% | 69 |
|
|
2015
Q1 | $525K | Buy |
5,027
+325
| +7% | +$33.9K | 0.22% | 71 |
|
|
2014
Q4 | $457K | Sell |
4,702
-151
| -3% | -$14.7K | 0.19% | 74 |
|
|
2014
Q3 | $380K | Sell |
4,853
-25
| -0.5% | -$1.96K | 0.17% | 79 |
|
|
2014
Q2 | $309K | Buy |
4,878
+120
| +3% | +$7.6K | 0.14% | 84 |
|
|
2014
Q1 | $320K | Sell |
4,758
-4,662
| -49% | -$314K | 0.16% | 77 |
|
|
2013
Q4 | $606K | Sell |
9,420
-235
| -2% | -$15.1K | 0.3% | 65 |
|
|
2013
Q3 | $618K | Sell |
9,655
-275
| -3% | -$17.6K | 0.34% | 63 |
|
|
2013
Q2 | $308K | Buy |
+9,930
| New | +$308K | 0.18% | 76 |
|